147 related articles for article (PubMed ID: 20639814)
1. PET imaging of the immune system: immune monitoring at the whole body level.
Singh AS; Radu CG; Ribas A
Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):281-90. PubMed ID: 20639814
[TBL] [Abstract][Full Text] [Related]
2. PET Imaging for Monitoring Cellular and Immunotherapy of Cancer.
Larimer BM
Cancer J; 2024 May-Jun 01; 30(3):153-158. PubMed ID: 38753749
[TBL] [Abstract][Full Text] [Related]
3. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the potential of noninvasive in vivo preclinical imaging of the immune system: challenges and prospects.
Diken M; Pektor S; Miederer M
Nanomedicine (Lond); 2016 Oct; 11(20):2711-2722. PubMed ID: 27628499
[TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging of Immunotherapy Targets in Cancer.
Ehlerding EB; England CG; McNeel DG; Cai W
J Nucl Med; 2016 Oct; 57(10):1487-1492. PubMed ID: 27469363
[TBL] [Abstract][Full Text] [Related]
6. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
7. Imaging the Tumor Microenvironment.
Abadjian MZ; Edwards WB; Anderson CJ
Adv Exp Med Biol; 2017; 1036():229-257. PubMed ID: 29275475
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive imaging of adaptive immunity using positron emission tomography.
Nair-Gill ED; Shu CJ; Radu CG; Witte ON
Immunol Rev; 2008 Feb; 221():214-28. PubMed ID: 18275485
[TBL] [Abstract][Full Text] [Related]
9. Adoptive T-cell therapy: a need for standard immune monitoring.
Klaver Y; Kunert A; Sleijfer S; Debets R; Lamers CH
Immunotherapy; 2015; 7(5):513-33. PubMed ID: 26065477
[TBL] [Abstract][Full Text] [Related]
10. Tracking cellular and immune therapies in cancer.
Kurtz DM; Gambhir SS
Adv Cancer Res; 2014; 124():257-96. PubMed ID: 25287692
[TBL] [Abstract][Full Text] [Related]
11. In-vivo imaging of tumor-infiltrating immune cells: implications for cancer immunotherapy.
Zeelen C; Paus C; Draper D; Heskamp S; Signore A; Galli F; Griessinger CM; Aarntzen EH
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):56-77. PubMed ID: 29191000
[TBL] [Abstract][Full Text] [Related]
12. Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing.
Saeed M; Xu Z; De Geest BG; Xu H; Yu H
Bioconjug Chem; 2020 Feb; 31(2):404-415. PubMed ID: 31951380
[TBL] [Abstract][Full Text] [Related]
13. Overcoming tumor-mediated immunosuppression.
Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive PET Imaging of T cells.
Wei W; Jiang D; Ehlerding EB; Luo Q; Cai W
Trends Cancer; 2018 May; 4(5):359-373. PubMed ID: 29709260
[TBL] [Abstract][Full Text] [Related]
15. Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET.
Bu L; Sun Y; Han G; Tu N; Xiao J; Wang Q
Curr Pharm Des; 2020; 26(6):675-687. PubMed ID: 31465273
[TBL] [Abstract][Full Text] [Related]
16.
McCarthy CE; White JM; Viola NT; Gibson HM
Front Immunol; 2020; 11():1067. PubMed ID: 32582173
[TBL] [Abstract][Full Text] [Related]
17. The role of PET in imaging of the tumour microenvironment and response to immunotherapy.
Lilburn DML; Groves AM
Clin Radiol; 2021 Oct; 76(10):784.e1-784.e15. PubMed ID: 34503671
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.
Weber J
Semin Oncol; 2010 Oct; 37(5):430-9. PubMed ID: 21074057
[TBL] [Abstract][Full Text] [Related]
19. [Development of novel immunotherapy targeting cancer immune evasion].
Tamada K
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
[TBL] [Abstract][Full Text] [Related]
20. Advances in PET Detection of the Antitumor T Cell Response.
McCracken MN; Tavaré R; Witte ON; Wu AM
Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
